CN1039999C - 后叶加压素拮抗物和催产素拮抗物其制备方法和含有它们的药物 - Google Patents
后叶加压素拮抗物和催产素拮抗物其制备方法和含有它们的药物 Download PDFInfo
- Publication number
- CN1039999C CN1039999C CN93119219A CN93119219A CN1039999C CN 1039999 C CN1039999 C CN 1039999C CN 93119219 A CN93119219 A CN 93119219A CN 93119219 A CN93119219 A CN 93119219A CN 1039999 C CN1039999 C CN 1039999C
- Authority
- CN
- China
- Prior art keywords
- group
- substituted
- lower alkyl
- formula
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electric Connection Of Electric Components To Printed Circuits (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27758992 | 1992-10-16 | ||
| JP277589/92 | 1992-10-16 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB971231559A Division CN1306935C (zh) | 1992-10-16 | 1993-10-16 | 后叶加压素拮抗物和催产素拮抗物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1098716A CN1098716A (zh) | 1995-02-15 |
| CN1039999C true CN1039999C (zh) | 1998-09-30 |
Family
ID=17585569
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93119219A Expired - Lifetime CN1039999C (zh) | 1992-10-16 | 1993-10-16 | 后叶加压素拮抗物和催产素拮抗物其制备方法和含有它们的药物 |
| CNB971231559A Expired - Lifetime CN1306935C (zh) | 1992-10-16 | 1993-10-16 | 后叶加压素拮抗物和催产素拮抗物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB971231559A Expired - Lifetime CN1306935C (zh) | 1992-10-16 | 1993-10-16 | 后叶加压素拮抗物和催产素拮抗物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5622947A (enExample) |
| EP (2) | EP1902717A3 (enExample) |
| KR (1) | KR100291816B1 (enExample) |
| CN (2) | CN1039999C (enExample) |
| AT (1) | ATE383861T1 (enExample) |
| AU (1) | AU663628B2 (enExample) |
| CA (1) | CA2124696C (enExample) |
| DE (1) | DE69334199T2 (enExample) |
| DK (1) | DK0620003T3 (enExample) |
| ES (1) | ES2300101T3 (enExample) |
| MX (1) | MX9306425A (enExample) |
| TW (1) | TW270927B (enExample) |
| WO (1) | WO1994008582A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW270927B (enExample) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd | |
| ES2121213T3 (es) * | 1993-07-15 | 1998-11-16 | Pfizer | Benciloxiquinuclidinas como antagonistas de la sustancia p. |
| DK1221440T3 (da) * | 1994-06-15 | 2007-09-17 | Otsuka Pharma Co Ltd | Benzoheterocykliske derivater der er nyttige som vasopressin- eller oxytocinmodulatorer |
| US5696112A (en) * | 1995-01-17 | 1997-12-09 | American Cyanamid Company | Fused heterocyclic azepines as vasopressin antagonists |
| TW359669B (en) * | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
| EP1050308A4 (en) | 1998-01-28 | 2002-09-04 | Senju Pharma Co | PROPHYLACTIC MEASURES OR REMEDIES AGAINST VISION DISORDERS |
| WO1999049870A1 (en) * | 1998-03-27 | 1999-10-07 | Oregon Health Sciences University | Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders |
| GB2355454A (en) * | 1999-10-20 | 2001-04-25 | Ferring Bv | Antidiuretic agents |
| GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| US7229986B2 (en) | 2000-05-16 | 2007-06-12 | Takeda Pharmaceutical Company Ltd. | Melanin-concentrating hormone antagonist |
| US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
| US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| KR20040015191A (ko) | 2001-04-27 | 2004-02-18 | 미쯔비시 웰 파마 가부시키가이샤 | 신규 벤질피페리딘 화합물 |
| CN1606554B (zh) * | 2001-10-12 | 2013-03-20 | 阿泽范药品公司 | β-内酰胺后叶加压素V1a拮抗剂 |
| ATE438626T1 (de) * | 2001-11-16 | 2009-08-15 | Astellas Pharma Inc | 4,4-difluor-1,2,3,4-tetrahydro-5h-1- benzazepinderivate und deren salze |
| US7749992B2 (en) * | 2003-10-08 | 2010-07-06 | Eli Lilly And Company | Compounds and methods for treating dislipidemia |
| TWI459947B (zh) * | 2007-06-26 | 2014-11-11 | Otsuka Pharma Co Ltd | 苯并氮呯化合物及藥學製劑 |
| CN102030709B (zh) * | 2009-09-25 | 2013-10-16 | 江苏豪森医药集团有限公司 | 用作加压素受体拮抗剂的苯并氮杂卓类化合物 |
| WO2018052967A1 (en) * | 2016-09-13 | 2018-03-22 | Arbutus Biopharma, Inc. | Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same |
| WO2019003433A1 (ja) | 2017-06-30 | 2019-01-03 | 大塚製薬株式会社 | ベンゾアゼピン誘導体 |
| CN112851583B (zh) * | 2021-01-19 | 2023-09-08 | 徐州医科大学 | 新型苯并氮杂䓬类化合物、组合物及其用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991005549A1 (en) * | 1989-10-20 | 1991-05-02 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds |
| CN1066653A (zh) * | 1991-04-19 | 1992-12-02 | 大制药株式会社 | 苯并杂环化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3542760A (en) * | 1966-04-25 | 1970-11-24 | American Home Prod | 7-alkoxy-2,3,4,5-tetrahydro-1h-1-benzazepine and derivatives thereof |
| US3516987A (en) * | 1966-04-25 | 1970-06-23 | American Home Prod | 1-methylsulfonyl-7-methoxy-2,3,4,5-tetrahydro-1h-1-benzazepine |
| JP2905909B2 (ja) * | 1991-04-19 | 1999-06-14 | 大塚製薬株式会社 | バソプレシン拮抗剤 |
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| TW270927B (enExample) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd |
-
1993
- 1993-10-14 TW TW082108510A patent/TW270927B/zh not_active IP Right Cessation
- 1993-10-15 EP EP07021546A patent/EP1902717A3/en not_active Withdrawn
- 1993-10-15 WO PCT/JP1993/001483 patent/WO1994008582A1/ja not_active Ceased
- 1993-10-15 MX MX9306425A patent/MX9306425A/es active IP Right Grant
- 1993-10-15 ES ES93922637T patent/ES2300101T3/es not_active Expired - Lifetime
- 1993-10-15 CA CA002124696A patent/CA2124696C/en not_active Expired - Lifetime
- 1993-10-15 DE DE69334199T patent/DE69334199T2/de not_active Expired - Lifetime
- 1993-10-15 KR KR1019940702053A patent/KR100291816B1/ko not_active Expired - Lifetime
- 1993-10-15 US US08/244,424 patent/US5622947A/en not_active Expired - Lifetime
- 1993-10-15 AT AT93922637T patent/ATE383861T1/de active
- 1993-10-15 AU AU51614/93A patent/AU663628B2/en not_active Expired
- 1993-10-15 DK DK93922637T patent/DK0620003T3/da active
- 1993-10-15 EP EP93922637A patent/EP0620003B1/en not_active Expired - Lifetime
- 1993-10-16 CN CN93119219A patent/CN1039999C/zh not_active Expired - Lifetime
- 1993-10-16 CN CNB971231559A patent/CN1306935C/zh not_active Expired - Lifetime
-
1996
- 1996-10-15 US US08/732,595 patent/US5753644A/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991005549A1 (en) * | 1989-10-20 | 1991-05-02 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds |
| CN1066653A (zh) * | 1991-04-19 | 1992-12-02 | 大制药株式会社 | 苯并杂环化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2300101T3 (es) | 2008-06-01 |
| AU663628B2 (en) | 1995-10-12 |
| CN1098716A (zh) | 1995-02-15 |
| EP0620003B1 (en) | 2008-01-16 |
| KR100291816B1 (ko) | 2001-10-24 |
| CA2124696C (en) | 2005-01-04 |
| ATE383861T1 (de) | 2008-02-15 |
| EP1902717A2 (en) | 2008-03-26 |
| DE69334199D1 (de) | 2008-03-06 |
| TW270927B (enExample) | 1996-02-21 |
| WO1994008582A1 (fr) | 1994-04-28 |
| CA2124696A1 (en) | 1994-04-28 |
| MX9306425A (es) | 1994-05-31 |
| EP0620003A1 (en) | 1994-10-19 |
| EP1902717A3 (en) | 2008-08-06 |
| AU5161493A (en) | 1994-05-09 |
| CN1183277A (zh) | 1998-06-03 |
| US5622947A (en) | 1997-04-22 |
| CN1306935C (zh) | 2007-03-28 |
| DK0620003T3 (da) | 2008-05-26 |
| US5753644A (en) | 1998-05-19 |
| EP0620003A4 (en) | 1995-02-15 |
| DE69334199T2 (de) | 2009-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1039999C (zh) | 后叶加压素拮抗物和催产素拮抗物其制备方法和含有它们的药物 | |
| CN1104418C (zh) | 苯并杂环衍生物 | |
| CN1035670C (zh) | 一种制备苯并杂环化合物或其盐的方法 | |
| CN1052224C (zh) | 哌啶衍生物、含有它的外周血管舒张剂及其应用 | |
| CN1158256C (zh) | 吡咯烷衍生物-ccr-3受体拮抗剂 | |
| CN1048484C (zh) | 含苯并杂环化合物的药物组合物的制备方法 | |
| CN1058710C (zh) | 苯甲酰胺衍生物及其制法、用途和含其的药物组合物 | |
| CN1227236C (zh) | 取代的咪唑神经肽yy5受体拮抗剂 | |
| CN1040748C (zh) | 苯并吖庚因衍生物及其药物组合物和中间体 | |
| CN1105706C (zh) | 用作氧化氮合成酶抑制剂的环状脒基制剂 | |
| CN1285588C (zh) | 法尼基蛋白转移酶抑制剂 | |
| CN1434805A (zh) | 选择性神经激肽拮抗剂 | |
| CN1498212A (zh) | 新螺三环衍生物及其作为磷酸二酯酶-7抑制剂的应用 | |
| CN1154699A (zh) | 用作速激肽拮抗剂的(氮杂环丁-1-基烷基)内酰胺 | |
| CN1906166A (zh) | 新型吡啶衍生物及嘧啶衍生物(1) | |
| CN1067075C (zh) | 作为中性白细胞弹性蛋白酶抑制剂的吡咯并吡咯酮 | |
| CN1198160A (zh) | 噻唑衍生物 | |
| CN1098264C (zh) | 用于治疗变态反应疾病的取代的4－(1h－苯并咪唑－2－基－氨基)哌啶 | |
| CN1471524A (zh) | 作为抗肿瘤剂的新颖法呢基蛋白质转移酶抑制剂 | |
| JP2913082B2 (ja) | バソプレシン拮抗剤及びオキシトシン拮抗剤 | |
| CN1334811A (zh) | 三环类法尼基蛋白转移酶抑制剂 | |
| CN1738798A (zh) | 作为促生长素抑制素激动剂或拮抗剂的吲哚衍生物 | |
| HK1016973A1 (en) | Benzazepine derivatives with vasopressin agonistic activity | |
| HK1016973B (en) | Benzazepine derivatives with vasopressin agonistic activity | |
| HK1026700B (en) | 1,4-substituted cyclic amine derivatives or dihydroindole derivatives and medicament thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CX01 | Expiry of patent term |
Expiration termination date: 20131016 Granted publication date: 19980930 |